![]() Featured News
May 24, 2024
Many Bright Ideas Technologies Inc. Reports Financial Results for Q1, 2024.
April 19, 2024
Many Bright Ideas Technologies Inc. Reports Audited Financial Results for 2023.
November 24, 2023
Many Bright Ideas Technologies Inc. Reports Financial Results for Q3, 2023.
August 25, 2023
Many Bright Ideas Technologies Inc. Reports Financial Results for Q2, 2023.
May 26, 2023
Many Bright Ideas Technologies Inc. Reports Financial Results for Q1, 2023.
April 21, 2023
Many Bright Ideas Technologies Inc. Reports Audited Financial Results for 2022.
November 25, 2022
Many Bright Ideas Technologies Inc. Reports Financial Results for Q3, 2022.
August 26, 2022
Many Bright Ideas Technologies Inc. Reports Financial Results for Q2, 2022.
April 22, 2022
Med BioGene Inc. Reports Audited Financial Results for 2021
November 26, 2021
Med BioGene Inc. Reports Financial Results for Q3, 2021.
August 27, 2021
Med BioGene Inc. Reports Financial Results for Q2, 2021.
March 25, 2021
Med BioGene Inc. Reports Audited Financial Results for 2020.
November 06, 2020
Med BioGene Inc. Reports Financial Results for Q3, 2020.
April 29, 2020
Med BioGene Inc. Reports Audited Financial Results for 2019.
November 29, 2019
Med BioGene Inc. Reports Financial Results for Q3 2019.
April 16, 2019
Med BioGene Inc. Reports Audited Financial Results for 2018.
November 09, 2018
Med BioGene Inc. Reports Financial Results for Q3, 2018.
August 28, 2018
Med BioGene Inc. Reports Financial Results for Q2, 2018.
April 30, 2018
Med BioGene Inc. Reports Audited Financial Results for 2017.
November 22, 2017
Med BioGene Inc. Reports Financial Results for Q3 2017.
June 21, 2015
From activist to CEO, how Iain Weir Jones landed the top job at Med Bio-Gene
September 05, 2014
Directors Nominated By Dissident Shareholder Elected At Annual General Meeting
September 04, 2014
Med BioGene Announces Receipt of Proxies for Upcoming Annual and Special Meeting
August 06, 2014
Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting
| Welcome to Med BioGene
On April 15, 2011, Precision Therapeutics, Inc. and Med BioGene closed their commercialization agreement. The agreement provides to Precision exclusive global rights to develop and commercialize GeneFx Lung. For more information on Precision Therapeutics, please see www.precisiontherapeutics.com. |
|
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer